99.81
Schlusskurs vom Vortag:
$99.84
Offen:
$99.36
24-Stunden-Volumen:
57,431
Relative Volume:
0.77
Marktkapitalisierung:
$1.27B
Einnahmen:
$69.48M
Nettoeinkommen (Verlust:
$18.64M
KGV:
68.36
EPS:
1.46
Netto-Cashflow:
$13.01M
1W Leistung:
+4.00%
1M Leistung:
+0.56%
6M Leistung:
+40.58%
1J Leistung:
+80.15%
Iradimed Corp Stock (IRMD) Company Profile
Firmenname
Iradimed Corp
Sektor
Branche
Telefon
(407) 677-8022
Adresse
12705 INGENUITY DRIVE, ORLANDO
Compare IRMD vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
IRMD
Iradimed Corp
|
99.81 | 1.27B | 69.48M | 18.64M | 13.01M | 1.46 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-04-12 | Eingeleitet | Lake Street | Buy |
| 2017-10-31 | Fortgesetzt | ROTH Capital | Buy |
| 2016-10-05 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2015-11-02 | Bestätigt | ROTH Capital | Buy |
| 2015-07-30 | Bestätigt | ROTH Capital | Buy |
| 2015-06-16 | Bestätigt | ROTH Capital | Buy |
| 2015-01-12 | Bestätigt | ROTH Capital | Buy |
| 2014-12-23 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Iradimed Corp Aktie (IRMD) Neueste Nachrichten
Allen Monty K sells IRADIMED (IRMD) shares worth $100,256 - Investing.com
Director Monty Allen Sells 1,000 Shares of iRadimed Corp (IRMD) - GuruFocus
IRADIMED Record Revenue Streak Supports 3870 Pump Rollout And Dividend Growth - Sahm
Iradimed Corp Eyes 2026 Surge After Strong Quarter - The Globe and Mail
iRadimed price target raised to $120 from $100 at Lake Street - TipRanks
IRadimed Corporation (NASDAQ:IRMD) Q4 2025 Earnings Call Transcript - Insider Monkey
How IRADIMED CORPORATION stock reacts to global recession fears2025 Geopolitical Influence & Weekly Setup with High ROI Potential - mfd.ru
Iradimed (IRMD) Earnings Beat With 26.8% Margin Tests High Valuation Narratives - Sahm
iRadimed (NASDAQ:IRMD) Hits New 12-Month High After Better-Than-Expected Earnings - Defense World
Why Iradimed Stock Soared Today - Yahoo Finance
Why Iradimed Stock Soared Today - The Motley Fool
iRadimed Corporation (NASDAQ:IRMD) to Issue Quarterly Dividend of $0.20 - MarketBeat
iRadimed Q4 Earnings Call Highlights - MarketBeat
Iradimed Co stock hits all-time high at 105.81 USD - Investing.com
IRadimed: Fourth Quarter Financial Highlights - Bitget
Earnings call transcript: Iradimed Co beats Q4 2025 forecasts, stock rises - Investing.com
IRMD Achieves Record Q4 Revenue with Strong Growth - GuruFocus
iRadimed (NASDAQ:IRMD) Sets New 12-Month High on Better-Than-Expected Earnings - MarketBeat
iRadimed (NASDAQ:IRMD) Updates FY 2026 Earnings Guidance - MarketBeat
iRadimed (NASDAQ:IRMD) Issues Q1 2026 Earnings Guidance - MarketBeat
IRadimed: Q4 Earnings Snapshot - kens5.com
iRadimed (NASDAQ:IRMD) Posts Earnings Results - MarketBeat
IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results - TradingView
Uncovering Potential: iRadimed's Earnings Preview - Benzinga
Iradimed earnings on deck with 3870 pump launch in focus By Investing.com - Investing.com South Africa
Iradimed earnings on deck with 3870 pump launch in focus - Investing.com
Analysts Are Bullish on Top Healthcare Stocks: Iradimed (IRMD), Inotiv (NOTV) - The Globe and Mail
Ranger Investment Management L.P. Lowers Stake in iRadimed Corporation $IRMD - MarketBeat
iRadimed (IRMD) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
IRADIMED CORPORATION to Hold Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 10, 2026 - stocktitan.net
Published on: 2026-02-02 13:48:08 - baoquankhu1.vn
Insider Transaction: Roger E Susi Sells $503K Worth Of iRadimed Shares - Benzinga
iRadimed (NASDAQ:IRMD) CEO Sells $503,250.00 in Stock - MarketBeat
IRADIMED Corp (NASDAQ:IRMD) Emerges as a Top Quality Stock from the Caviar Cruise Screen - Chartmill
IRADIMED CORPORATION's (NASDAQ:IRMD) Stock Is Going Strong: Is the Market Following Fundamentals? - Yahoo Finance
Iradimed stock hits all-time high of 104.67 USD - Investing.com
Insider Unloading: Roger E Susi Sells $509K Worth Of iRadimed Shares - Benzinga
How Record Q3 Results And FDA-Cleared MRI Pump Launch At IRADIMED (IRMD) Has Changed Its Investment Story - Sahm
Insider Selling: iRadimed (NASDAQ:IRMD) CEO Sells 5,000 Shares of Stock - MarketBeat
iRadimed (NASDAQ:IRMD) Hits New 52-Week HighStill a Buy? - MarketBeat
iRadimed Corporation (NASDAQ:IRMD) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
iRadimed Corporation (NASDAQ:IRMD) Given Average Rating of “Moderate Buy” by Analysts - Defense World
iRadimed Corporation (NASDAQ:IRMD) Short Interest Update - MarketBeat
IRadimed Corporation (IRMD): Accelerating with Solid Capital Return - Yahoo Finance
iRadimed (NASDAQ:IRMD) Reaches New 52-Week HighHere's Why - MarketBeat
Iradimed stock hits all-time high at 100.55 USD - Investing.com
CEO Of iRadimed Makes $487K Sale - Benzinga
Iradimed CEO Susi sells $487k in shares By Investing.com - Investing.com Australia
Iradimed CEO Susi sells $487k in shares - Investing.com
Iradimed Insider Sold Shares Worth $487,231, According to a Recent SEC Filing - marketscreener.com
Will IRADIMED CORPORATION stock maintain momentum in 2025 - Улправда
Finanzdaten der Iradimed Corp-Aktie (IRMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):